Meridian Bioscience, Inc., a life sciences company, develops, manufactures, distributes and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases and elevated blood lead levels worldwide. The company is headquartered in Cincinnati, Ohio.
| Revenue (TTM) | 61,000 |
| Gross Profit (TTM) | 11,000 |
| EBITDA | $-8.27M |
| Operating Margin | -0.52% |
| Return on Equity | 0.00% |
| Return on Assets | -8.10% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $1.30 |
| Price-to-Book | 2.16 |
| Price-to-Sales (TTM) | 641.33 |
| EV/Revenue | 1117.37 |
| EV/EBITDA | -4.11 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 47.60% |
| Shares Outstanding | $16.79M |
| Float | $9.81M |
| % Insiders | 25.53% |
| % Institutions | 4.48% |